U.S. FDA Panel Addresses Oximeter's Effectivity on Darker Skin Tones as 'Critical' Amidst COVID-19
The U.S. FDA will hold a meeting to discuss the underlying flaw of the oximeter after Health professionals and researchers called out the agency.
United States Rutendo Jakachira Owais Durrani Therapy Devices Panel Drug Administration Brown University
Source: techtimes.com